Moderate Alcohol Consumption and Heart Function in Patients With a Recent Myocardial Infarction

NARecruitingINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Myocardial Infarction
Interventions
BEHAVIORAL

Alcohol consumption

After written consent, patients will enter a run-in period of 2 weeks where they will be asked not to drink any alcohol beverage. Patients with a successful run-in period will be randomized on a 1:1 basis stratified by baseline LVEF (\<50% vs. ≥50%), sex and study site. 110 patients will be assigned to moderate alcohol consumption (1 standard unit a day), and 110 patients to abstinence (no alcohol beverages) for 3 months. We will perform a first echocardiography at randomization and a second at 3 months' follow-up.

Trial Locations (3)

1005

RECRUITING

Centre hospitalier universitaire vaudois, Lausanne

1205

RECRUITING

Hôpitaux Universitaires de Genève, Geneva

3010

RECRUITING

Inselspital, Bern

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

University of Bern

OTHER

collaborator

Swiss National Science Foundation

OTHER

lead

Baris Gencer

OTHER